The case titled "Modi-Mundipharma Pvt. Ltd. Vs. Lloyd Health Care Pvt. Ltd. & Anr." (Case Number CS(COMM) 877/2025) was ordered on August 22, 2025, in the High Court of Delhi before Hon'ble Mr. Justice Tejas Karia.
Summary:
This suit involves a trademark infringement dispute where Modi-Mundipharma Pvt. Ltd. (Plaintiff) alleges that Lloyd Health Care Pvt. Ltd. & Anr. (Defendants) infringed its registered trademarks belonging to the CONTIN Series of Marks, specifically the "NITROCONTIN" mark used for pharmaceutical products. The Plaintiff, claiming significant goodwill and multiple registrations for CONTIN marks since 1982, contended that the Defendants marketed medicinal products under the confusingly similar mark "LOYCONTIN" for identical products (nitroglycerin controlled release tablets in 2.6 mg and 6.4 mg dosages). The Plaintiff sent cease-and-desist notices which the Defendants either refused or did not respond to and also noticed the Defendants filing a trademark application for the mark "LOY CTN." The Court found a prima facie case in favor of the Plaintiff for an ex-parte ad-interim injunction restraining the Defendants from manufacturing, selling, or distributing products under the infringing marks. The case was listed for further hearing in December 2025.
Disclaimer: The information shared here is intended to serve the public interest by offering insights and perspectives. However, readers are advised to exercise their own discretion when interpreting and applying this information. The content herein is subjective and may contain errors in perception, interpretation, and presentation.
Written By: Advocate Ajay Amitabh Suman, IP Adjutor [Patent and Trademark Attorney], High Court of Delhi
No comments:
Post a Comment